HighVista Strategies LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
HighVista Strategies LLC disclosed 156 US equity positions worth $362.2m in its Q1 2026 13F filing. The largest position was DBC at 8.5% of the reported book, followed by ABVX and PRAX.
What did HighVista Strategies LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | DBC INVESCO DB COMMDY INDX TRCK | 8.5% | $30.6m | 1,057,238 | – | ||
| 2 | ABVX ABIVAX SA | Healthcare | 3.5% | $12.6m | 113,254 | – | |
| 3 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.3% | $8.5m | 26,323 | – | |
| 4 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.1% | $7.6m | 197,051 | – | |
| 5 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 2.0% | $7.4m | 146,264 | – | |
| 6 | PCVX VAXCYTE INC | Healthcare | 2.0% | $7.2m | 124,647 | – | |
| 7 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.9% | $6.7m | 69,309 | – | |
| 8 | 430 TERNS PHARMACEUTICALS INC | 1.7% | $6.0m | 114,307 | – | ||
| 9 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.6% | $6.0m | 123,909 | – | |
| 10 | NUVALENT INC | 1.6% | $5.8m | 56,602 | – | ||
| 11 | IMVT IMMUNOVANT INC | Healthcare | 1.5% | $5.6m | 225,139 | – | |
| 12 | SLNOEUR SOLENO THERAPEUTICS INC | 1.5% | $5.5m | 165,227 | – | ||
| 13 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.4% | $5.0m | 131,304 | – | |
| 14 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 1.4% | $4.9m | 352,085 | – | |
| 15 | AMZN AMAZON COM INC | Consumer Cyclical | 1.3% | $4.7m | 22,397 | – | |
| 16 | LB PHARMACEUTICALS INC | 1.2% | $4.3m | 173,595 | – | ||
| 17 | RLAY RELAY THERAPEUTICS INC | Healthcare | 1.2% | $4.2m | 421,881 | – | |
| 18 | INSM INSMED INC | Healthcare | 1.1% | $4.0m | 24,316 | – | |
| 19 | NVDA NVIDIA CORPORATION | Technology | 1.1% | $3.9m | 22,420 | – | |
| 20 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.1% | $3.9m | 78,911 | – | |
| 21 | CYTK CYTOKINETICS INC | Healthcare | 1.1% | $3.9m | 58,643 | – | |
| 22 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.0% | $3.8m | 99,744 | – | |
| 23 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.0% | $3.7m | 441,573 | – | |
| 24 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.0% | $3.7m | 52,464 | – | |
| 25 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 1.0% | $3.7m | 49,560 | – | |
| 26 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 1.0% | $3.6m | 193,955 | – | |
| 27 | ARGX ARGENX SE | Healthcare | 1.0% | $3.6m | 4,918 | – | |
| 28 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.0% | $3.6m | 33,852 | – | |
| 29 | PALI PALISADE BIO INC | Healthcare | 1.0% | $3.5m | 2,019,326 | – | |
| 30 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 1.0% | $3.5m | 185,856 | – | |
| 31 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.0% | $3.5m | 226,546 | – | |
| 32 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 1.0% | $3.5m | 20,437 | – | |
| 33 | IVA INVENTIVA SA | 0.9% | $3.4m | 615,666 | – | ||
| 34 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $3.3m | 182,929 | – | |
| 35 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 35,761 | – | |
| 36 | GHRS GH RESEARCH PLC | Healthcare | 0.8% | $3.0m | 213,212 | – | |
| 37 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 35,587 | – | |
| 38 | MAZE MAZE THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 99,850 | – | |
| 39 | ERAS ERASCA INC | Healthcare | 0.8% | $2.9m | 181,069 | – | |
| 40 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 0.8% | $2.9m | 91,931 | – | |
| 41 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 0.8% | $2.9m | 73,102 | – | |
| 42 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.8% | $2.9m | 49,050 | – | |
| 43 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.8% | $2.8m | 89,397 | – | |
| 44 | VERA VERA THERAPEUTICS INC | Healthcare | 0.8% | $2.8m | 69,241 | – | |
| 45 | PHVS PHARVARIS N V | Healthcare | 0.8% | $2.8m | 97,866 | – | |
| 46 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.7% | $2.6m | 134,229 | – | |
| 47 | ALKS ALKERMES PLC | Healthcare | 0.7% | $2.6m | 73,189 | – | |
| 48 | ALMS ALUMIS INC | Healthcare | 0.7% | $2.5m | 112,929 | – | |
| 49 | MSFT MICROSOFT CORP | Technology | 0.7% | $2.4m | 6,457 | – | |
| 50 | EYPT EYEPOINT INC | Healthcare | 0.7% | $2.4m | 183,037 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.